Skip to main content

We’ve updated our Terms & Conditions and Privacy Policy. By using this site, you agree to these terms.

Geisinger becomes the first member of Risant Health

DANVILLE, Pa. – The increased availability of testing is a key factor in defeating COVID-19 in our communities, and as Geisinger works to test patients in central and northeast Pennsylvania, the laboratory in Danville has been working around the clock to give accurate and quick results.

To help protect our communities and to equip the laboratory with the necessary tools to do so, Geisinger used donated funds to purchase a new Hologic Panther Fusion System. The new equipment aligns with existing instruments to increase capacity and efficiency for the Geisinger laboratory.

“The Panther system has received FDA approval for emergency use for epidemiologic testing of respiratory samples for COVID-19,” said Raquel M. Martinez, Ph.D., system director of Microbial Diagnostics. “What that means is that it gives our laboratory the ability to participate in testing of high-risk patient populations, such as nursing homes and others that may be required of us as the state reopens elective surgery and we return to clinic openings.”

The new equipment increased Geisinger’s testing capacity by more than 70 percent, a jump from the processing 5,528 tests per week to 21,278 tests per week. That larger capacity provides greater access to testing for the community, allowing for faster diagnosis and effective containment and contact tracing. Having the higher testing capacity also allows Geisinger’s caregivers to quickly rule out possible COVID-19 exposure, saving PPE for inpatients.  

In addition, the Panther instrument is robotic and automated and records and stores the results in the laboratory information system, according to Donna M. Wolk, Ph.D., division director of Molecular and Microbial Diagnostics and Development at Geisinger.

“This equipment saves us time by saving our laboratory scientists from needing to manually type in results so they can instead they review the results for validity. The instrument is low-maintenance, low- waste and provides high accuracy and reproducibility,” Dr. Wolk said.

The cost for this equipment is nearly $300,000, of which $250,000 was offset by philanthropic funds.

To donate to the fight against COVID-19, please visit or call 800-739-6882.

About Geisinger
Geisinger is among the nation’s leading providers of value-based care, serving 1.2 million people in urban and rural communities across Pennsylvania. Founded in 1915 by philanthropist Abigail Geisinger, the non-profit system generates $10 billion in annual revenues across 134 care sites - including 10 hospital campuses, and Geisinger Health Plan, with 600,000 members in commercial and government plans. The Geisinger College of Health Sciences educates more than 5,000 medical professionals annually and conducts more than 1,400 clinical research studies. With 26,000 employees, including 1,600 employed physicians, Geisinger is among Pennsylvania’s largest employers with an estimated economic impact of $14 billion to the state’s economy. On March 31, 2024, Geisinger became the first member of Risant Health, a new nonprofit charitable organization created to expand and accelerate value-based care across the country.  Learn more at or connect with us on Facebook, Instagram, LinkedIn and X.

COVID-19 testing machines in Geisinger's laboratory.
Geisinger utilized donated funds from Hologic Panther Fusion System to help equip the system's laboratory testing capacity. 

Media inquires:

Mike McMullen
Communication Specialist


Content from General Links with modal content